Pot Stock Grows on Plant Expansion

ACB cited growth in global demand for medical pot

by Lillian Currens

Published on Apr 10, 2019 at 10:04 AM

Canadian marijuana concern Aurora Cannabis Inc (NYSE:ACB) just announced that is will be expanding its Aurora Sun production facility in Alberta by 33% more than initially planned, in order to meet the ever-growing global demand for medical-grade marijuana. The shares of ACB are inching higher in response, up 1% at $8.89, at last check. 

ACB stock has staged an impressive rebound off its four-month low of $4.58 in late-December, adding roughly 94% in that time frame. In fact, the shares just ended their best quarter since December 2017. The equity spiked to a year-to-date high of $10.32 on March 19, but has since pulled back to its 30-day moving average -- a trendline that's served as an area of support during ACB's 2019 rally. 

Despite its outperformance this year, analysts are cautious on the pot stock. Two have doled out a tepid "hold" rating, and only one gives it a "strong buy." An extended rally could bring bullish analyst initiations of upgrades for Aurora Cannabis shares.

Options traders are taking a more bullish approach. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), nearly seven calls have been bought to open for every put in the past 10 trading days. Short interest is on the decline, too, down 5.2% in the last reporting period. The 73.11 million shares sold short now represent less than 8% of ACB's total available float. 

From Schaeffer's Pro Traders
Trade Weekly Options Like a Pro

Direct from our Schaeffer's traders, your FREE guide to profiting with weeklies!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Cannabis Up-and-Comer Focuses on Streamlined Growth
This early-staged CBD stock may be setting up investors for big gains.
Drug Stock Doubles on Trial Update
ETON is another name making a big move in the healthcare space
Wall Street Dishes Out "Sell" Ratings on Healthcare Stocks
Multiple bear notes have hit the healthcare sector today
Cannabis Up-and-Comer Focuses on Streamlined Growth
This early-staged CBD stock may be setting up investors for big gains.